<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37350206</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-629X</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>5-6</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Revue medicale de Liege</Title><ISOAbbreviation>Rev Med Liege</ISOAbbreviation></Journal><ArticleTitle>[An emerging cause of chronic fatigue and pain : post-COVID-19 condition or long COVID].</ArticleTitle><Pagination><StartPage>299</StartPage><EndPage>304</EndPage><MedlinePgn>299-304</MedlinePgn></Pagination><Abstract><AbstractText>Some individuals who have been infected with SARS-CoV-2 can experience long-term effects from their infection, known as post-COVID conditions, post-acute sequelae of COVID-19 or long COVID. Different underlying mechanisms can lead to long COVID, none of which are mutually exclusive. Lingering symptoms can persist years after SARS-CoV-2 infection, including fatigue, muscle weakness, tachycardia, dyspnea and various neurological symptoms. The symptomatology is partly similar to that reported by people with chronic fatigue syndrome and other unwell studied long-lasting diseases that may occur after other infections. People who have experienced more severe COVID-19 illness are at higher risk of developing long COVID, although anyone who was infected can experience post-COVID conditions. Importantly, unvaccinated individuals are more likely to develop long COVID. Here we review the current knowledge and discuss key findings regarding the epidemiology and physiopathology of long COVID. We briefly review current diagnostic and treatment options that remain so far largely insufficient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Moussaoui</LastName><ForeName>Majdouline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service des Maladies infectieuses, CHU Li&#xe8;ge, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guiot</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de Pneumologie, CHU Li&#xe8;ge, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frippiat</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service des Maladies infectieuses, CHU Li&#xe8;ge, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darcis</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service des Maladies infectieuses, CHU Li&#xe8;ge, Belgique.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Une cause &#xe9;mergente de fatigue et de douleurs chroniques : l&#x2019;affection post-COVID-19 ou COVID long.</VernacularTitle></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Rev Med Liege</MedlineTA><NlmUniqueID>0404317</NlmUniqueID><ISSNLinking>0370-629X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Certains individus infect&#xe9;s par le SARS-CoV-2 peuvent pr&#xe9;senter des sympt&#xf4;mes &#xe0; long terme, &#xe9;voluant parfois durant plusieurs ann&#xe9;es. Il est alors question d&#x2019;affection post-COVID-19 ou COVID long. Les sympt&#xf4;mes sont tr&#xe8;s polymorphes, fluctuants, et comprennent, notamment, une fatigue intense, des douleurs articulaires et musculaires, de la dyspn&#xe9;e, de la tachycardie, ainsi qu&#x2019;une constellation de plaintes neurologiques. Cette symptomatologie est, en partie, similaire &#xe0; celle du syndrome de fatigue chronique et est retrouv&#xe9;e &#xe9;galement apr&#xe8;s d&#x2019;autres types d&#x2019;infections. Les m&#xe9;canismes &#xe0; l&#x2019;origine du COVID long sont probablement multiples et encore mal connus. Si le COVID long peut toucher tout individu infect&#xe9; par le SARS-CoV-2, certains groupes sont plus &#xe0; risque, notamment les personnes non vaccin&#xe9;es ou les individus ayant pr&#xe9;sent&#xe9; une infection s&#xe9;v&#xe8;re. Dans cet article, nous r&#xe9;sumons les connaissances actuelles et mettons en lumi&#xe8;re les d&#xe9;couvertes cl&#xe9;s quant &#xe0; l&#x2019;&#xe9;pid&#xe9;miologie et aux m&#xe9;canismes physiopathologiques du COVID long. Nous discutons aussi des crit&#xe8;res diagnostiques et des options th&#xe9;rapeutiques qui sont, &#xe0; ce jour, largement insuffisantes.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID conditions</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37350206</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>